361 is the total number of securities Avidity Partners Management LP has owned. The longest Avidity Partners Management LP has owned a single stock is 15 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| NBIX | NEUROCRINE BIOSCIENCES... | 12 | 3 | 0.93% | 2.34% | 4.61% | Q4 2019 | Q3 2023 | 15 |
| ARVN | ARVINAS INC | 14 | 14 | 1.48% | 3.40% | 4.93% | Q2 2020 | Q3 2023 | 14 |
| ZNTL | ZENTALIS PHARMACEUTICA... | 14 | 14 | 1.37% | 2.40% | 4.84% | Q2 2020 | Q3 2023 | 14 |
| SNDX | SYNDAX PHARMACEUTICALS... | 14 | 14 | 1.27% | 2.18% | 3.23% | Q2 2020 | Q3 2023 | 14 |
| IDYA | IDEAYA BIOSCIENCES INC | 11 | 2 | 0.61% | 1.33% | 2.45% | Q2 2020 | Q3 2023 | 13 |
| NTRA | NATERA INC | 13 | 13 | 0.46% | 1.33% | 1.86% | Q3 2020 | Q3 2023 | 13 |
| ALPN | ALPINE IMMUNE SCIENCES... | 13 | 13 | 0.15% | 0.32% | 0.51% | Q3 2020 | Q3 2023 | 13 |
| ABBV | ABBVIE INC | 11 | 1 | 2.44% | 5.10% | 9.72% | Q4 2019 | Q2 2023 | 12 |
| HZNP | HORIZON THERAPEUTICS P... | 12 | 12 | 1.36% | 2.32% | 3.42% | Q4 2019 | Q3 2022 | 12 |
| AVTR | AVANTOR INC | 10 | 1 | 0.79% | 3.46% | 6.00% | Q2 2020 | Q1 2023 | 11 |
| VRTX | VERTEX PHARMACEUTICALS... | 9 | 2 | 1.08% | 2.91% | 5.52% | Q4 2019 | Q4 2022 | 11 |
| CTLT | CATALENT INC | 9 | 2 | 1.14% | 1.86% | 3.26% | Q4 2019 | Q3 2022 | 11 |
| IMCR | IMMUNOCORE HLDGS PLC | 11 | 11 | 0.63% | 1.06% | 1.98% | Q1 2021 | Q3 2023 | 11 |
| NTLA | INTELLIA THERAPEUTICS INC | 7 | 1 | 0.48% | 0.78% | 1.66% | Q2 2020 | Q3 2023 | 11 |
| SCYX | SCYNEXIS INC | 9 | 2 | 0.04% | 0.18% | 0.41% | Q4 2020 | Q3 2023 | 11 |
| NUVBWS | NUVATION BIO INC | 11 | 11 | 0.00% | 0.00% | 0.01% | Q1 2021 | Q3 2023 | 11 |
| LEGN | LEGEND BIOTECH CORP | 5 | 1 | 0.27% | 1.21% | 2.62% | Q2 2020 | Q3 2023 | 10 |
| AXSM | AXSOME THERAPEUTICS INC | 5 | 2 | 0.39% | 1.13% | 2.14% | Q1 2020 | Q3 2023 | 10 |
| ARWR | ARROWHEAD PHARMACEUTIC... | 10 | 10 | 0.23% | 1.03% | 1.47% | Q2 2021 | Q3 2023 | 10 |
| EPIX | ESSA PHARMA INC | 10 | 10 | 0.09% | 0.79% | 2.28% | Q3 2020 | Q4 2022 | 10 |
| BLU | BELLUS HEALTH INC NEW | 10 | 10 | 0.36% | 0.72% | 1.09% | Q4 2020 | Q1 2023 | 10 |
| KZR | KEZAR LIFE SCIENCES INC | 9 | 1 | 0.05% | 0.70% | 1.22% | Q1 2021 | Q3 2023 | 10 |
| ATEC | ALPHATEC HLDGS INC | 8 | 2 | 0.16% | 0.60% | 1.08% | Q4 2020 | Q3 2023 | 10 |
| IPSC | CENTURY THERAPEUTICS INC | 10 | 10 | 0.09% | 0.27% | 0.80% | Q2 2021 | Q3 2023 | 10 |
| CMAX | CAREMAX INC | 10 | 10 | 0.05% | 0.11% | 0.28% | Q2 2021 | Q3 2023 | 10 |
| HSAQ | HEALTH SCIENCES ACQ CO... | 10 | 10 | 0.08% | 0.11% | 0.20% | Q3 2020 | Q4 2022 | 10 |
| LLY | LILLY ELI & CO | 3 | 1 | 1.62% | 3.15% | 6.62% | Q4 2020 | Q3 2023 | 9 |
| AZN | ASTRAZENECA PLC | 6 | 1 | 0.63% | 3.12% | 5.31% | Q2 2020 | Q4 2022 | 9 |
| MRTX | MIRATI THERAPEUTICS INC | 7 | 2 | 2.12% | 3.08% | 5.20% | Q4 2019 | Q1 2022 | 9 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 9 | 9 | 1.37% | 2.94% | 5.18% | Q1 2020 | Q1 2022 | 9 |
| BIIB | BIOGEN INC | 3 | 1 | 1.19% | 2.18% | 4.15% | Q1 2020 | Q3 2023 | 9 |
| RARE | ULTRAGENYX PHARMACEUTI... | 9 | 9 | 0.78% | 1.70% | 3.00% | Q3 2021 | Q3 2023 | 9 |
| VIR | VIR BIOTECHNOLOGY INC | 5 | 1 | 0.21% | 0.75% | 1.63% | Q2 2020 | Q2 2023 | 9 |
| CARIBOU BIOSCIENCES INC | 9 | 9 | 0.37% | 0.69% | 1.31% | Q3 2021 | Q3 2023 | 9 | |
| COLL | COLLEGIUM PHARMACEUTIC... | 4 | 2 | 0.02% | 0.62% | 2.33% | Q4 2019 | Q3 2023 | 9 |
| PHAT | PHATHOM PHARMACEUTICAL... | 8 | 1 | 0.16% | 0.55% | 0.98% | Q4 2020 | Q3 2023 | 9 |
| ALT | ALTIMMUNE INC | 9 | 9 | 0.12% | 0.53% | 1.42% | Q3 2021 | Q3 2023 | 9 |
| ARGX | ARGENX SE | 7 | 1 | 0.15% | 2.82% | 5.13% | Q1 2021 | Q3 2023 | 8 |
| BSX | BOSTON SCIENTIFIC CORP... | 7 | 1 | 1.10% | 2.19% | 4.39% | Q3 2020 | Q3 2023 | 8 |
| BPMC | BLUEPRINT MEDICINES CORP | 6 | 2 | 0.39% | 1.33% | 2.26% | Q4 2020 | Q3 2023 | 8 |
| RNA | AVIDITY BIOSCIENCES INC | 7 | 1 | 0.42% | 0.85% | 1.57% | Q2 2020 | Q1 2023 | 8 |
| GRTS | GRITSTONE ONCOLOGY INC | 6 | 2 | 0.05% | 0.50% | 1.19% | Q4 2020 | Q3 2023 | 8 |
| SIBN | SI-BONE INC | 8 | 8 | 0.30% | 0.45% | 0.62% | Q4 2020 | Q3 2022 | 8 |
| CYT | CYTEIR THERAPEUTICS INC | 8 | 8 | 0.06% | 0.33% | 1.05% | Q2 2021 | Q1 2023 | 8 |
| ACIU | AC IMMUNE SA | 5 | 1 | 0.01% | 0.21% | 0.35% | Q3 2020 | Q3 2023 | 8 |
| ONCS | ONCOSEC MED INC | 8 | 8 | 0.03% | 0.18% | 0.46% | Q4 2020 | Q3 2022 | 8 |
| CMPX | COMPASS THERAPEUTICS INC | 8 | 8 | 0.06% | 0.14% | 0.22% | Q4 2021 | Q3 2023 | 8 |
| BLSA | BCLS ACQUISITION CORP | 8 | 8 | 0.10% | 0.13% | 0.18% | Q4 2020 | Q3 2022 | 8 |
| ARYD | ARYA SCIENCES ACQU COR... | 8 | 8 | 0.10% | 0.12% | 0.14% | Q1 2021 | Q4 2022 | 8 |
| HYPERFINE INC | 8 | 8 | 0.02% | 0.09% | 0.23% | Q4 2021 | Q3 2023 | 8 | |
| BAX | BAXTER INTL INC | 3 | 1 | 0.96% | 3.46% | 8.69% | Q4 2019 | Q2 2023 | 7 |
| UTHR | UNITED THERAPEUTICS CO... | 7 | 7 | 1.15% | 2.93% | 4.73% | Q2 2021 | Q4 2022 | 7 |
| SGEN | SEAGEN INC | 7 | 7 | 0.30% | 1.86% | 2.73% | Q1 2021 | Q3 2022 | 7 |
| SRPT | SAREPTA THERAPEUTICS INC | 5 | 1 | 1.08% | 1.81% | 2.96% | Q1 2020 | Q3 2023 | 7 |
| KDMN | KADMON HLDGS INC | 7 | 7 | 0.97% | 1.58% | 2.37% | Q4 2019 | Q2 2021 | 7 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 7 | 7 | 0.41% | 1.29% | 2.81% | Q4 2019 | Q2 2021 | 7 |
| ISEE | IVERIC BIO INC | 5 | 2 | 0.10% | 1.21% | 2.47% | Q2 2021 | Q1 2023 | 7 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 5 | 2 | 0.27% | 1.08% | 2.10% | Q2 2020 | Q3 2022 | 7 |
| AN2 THERAPEUTICS INC | 7 | 7 | 0.12% | 0.27% | 0.70% | Q1 2022 | Q3 2023 | 7 | |
| PHAS | PHASEBIO PHARMACEUTICA... | 7 | 7 | 0.02% | 0.23% | 0.43% | Q1 2021 | Q3 2022 | 7 |
| GRPH | GRAPHITE BIO INC | 7 | 7 | 0.04% | 0.20% | 0.61% | Q2 2021 | Q4 2022 | 7 |
| MSAC | MEDICUS SCIENCES ACQUI... | 7 | 7 | 0.10% | 0.11% | 0.14% | Q2 2021 | Q4 2022 | 7 |
| PANA | PANACEA ACQUISITION CO... | 7 | 7 | 0.10% | 0.11% | 0.14% | Q2 2021 | Q4 2022 | 7 |
| DNAB | SOCIAL CAP SUVRETTA HL... | 7 | 7 | 0.04% | 0.04% | 0.06% | Q2 2021 | Q4 2022 | 7 |
| DNAD | SOCIAL CAP SUVRETTA HL... | 7 | 7 | 0.04% | 0.04% | 0.06% | Q2 2021 | Q4 2022 | 7 |
| MSACW | MEDICUS SCIENCES ACQUI... | 7 | 7 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q4 2022 | 7 |
| REGN | REGENERON PHARMACEUTICALS | 3 | 1 | 0.62% | 2.75% | 5.28% | Q1 2020 | Q3 2023 | 6 |
| MCK | MCKESSON CORP | 2 | 2 | 1.21% | 2.39% | 4.54% | Q1 2020 | Q3 2023 | 6 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 6 | 6 | 0.22% | 2.35% | 4.16% | Q2 2022 | Q3 2023 | 6 |
| HUM | HUMANA INC | 3 | 1 | 0.99% | 2.15% | 4.43% | Q1 2020 | Q3 2023 | 6 |
| ACHC | ACADIA HEALTHCARE COMP... | 6 | 6 | 1.53% | 2.04% | 2.80% | Q2 2022 | Q3 2023 | 6 |
| AUPH | AURINIA PHARMACEUTICAL... | 6 | 6 | 0.64% | 1.98% | 2.96% | Q4 2019 | Q1 2021 | 6 |
| KRTX | KARUNA THERAPEUTICS INC | 6 | 6 | 0.59% | 1.93% | 3.35% | Q2 2022 | Q3 2023 | 6 |
| SGRY | SURGERY PARTNERS INC | 5 | 1 | 0.13% | 1.73% | 3.84% | Q4 2020 | Q3 2023 | 6 |
| PRTA | PROTHENA CORP PLC | 5 | 1 | 0.25% | 1.71% | 3.85% | Q2 2021 | Q3 2023 | 6 |
| NUVB | NUVATION BIO INC | 6 | 6 | 0.36% | 1.29% | 2.17% | Q1 2021 | Q2 2022 | 6 |
| CCXI | CHEMOCENTRYX INC | 2 | 2 | 0.50% | 1.28% | 2.38% | Q1 2020 | Q1 2022 | 6 |
| RVMD | REVOLUTION MEDICINES INC | 6 | 6 | 0.59% | 0.92% | 1.28% | Q2 2022 | Q3 2023 | 6 |
| ACAD | ACADIA PHARMACEUTICALS... | 3 | 1 | 0.15% | 0.90% | 2.08% | Q4 2019 | Q4 2021 | 6 |
| APLS | APELLIS PHARMACEUTICAL... | 3 | 1 | 0.22% | 0.90% | 1.49% | Q3 2020 | Q2 2023 | 6 |
| HARP | HARPOON THERAPEUTICS INC | 6 | 6 | 0.21% | 0.70% | 1.28% | Q2 2020 | Q3 2021 | 6 |
| RCKT | ROCKET PHARMACEUTICALS... | 4 | 1 | 0.09% | 0.68% | 1.31% | Q4 2019 | Q3 2023 | 6 |
| SPNE | SEASPINE HLDGS CORP | 6 | 6 | 0.23% | 0.52% | 0.84% | Q2 2021 | Q3 2022 | 6 |
| HLXA | HELIX ACQUISITION CORP | 6 | 6 | 0.08% | 0.11% | 0.15% | Q4 2020 | Q1 2022 | 6 |
| ANTM | ELEVANCE HEALTH INC | 4 | 1 | 1.92% | 3.25% | 4.89% | Q3 2020 | Q3 2022 | 5 |
| AKRO | AKERO THERAPEUTICS INC | 5 | 5 | 1.50% | 2.60% | 4.54% | Q3 2022 | Q3 2023 | 5 |
| IMAB | I MAB | 5 | 5 | 0.73% | 1.90% | 2.92% | Q3 2020 | Q3 2021 | 5 |
| ARNA | ARENA PHARMACEUTICALS INC | 5 | 5 | 1.50% | 1.78% | 2.40% | Q4 2020 | Q4 2021 | 5 |
| MDT | MEDTRONIC PLC | 5 | 5 | 0.87% | 1.64% | 3.34% | Q2 2020 | Q2 2021 | 5 |
| EXAS | EXACT SCIENCES CORP | 4 | 1 | 0.78% | 1.56% | 2.18% | Q4 2019 | Q3 2021 | 5 |
| DXCM | DEXCOM INC | 3 | 1 | 0.57% | 1.45% | 2.62% | Q4 2019 | Q3 2023 | 5 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 4 | 1 | 0.89% | 1.37% | 1.79% | Q1 2021 | Q3 2022 | 5 |
| XLRN | ACCELERON PHARMA INC | 4 | 1 | 0.13% | 1.17% | 2.06% | Q1 2020 | Q3 2021 | 5 |
| PCVX | VAXCYTE INC | 5 | 5 | 0.31% | 1.14% | 1.68% | Q3 2022 | Q3 2023 | 5 |
| SHC | SOTERA HEALTH CO | 5 | 5 | 0.62% | 1.11% | 1.48% | Q4 2020 | Q4 2021 | 5 |
| STTK | SHATTUCK LABS INC | 5 | 5 | 0.03% | 1.03% | 1.60% | Q4 2020 | Q4 2021 | 5 |
| ACET | ADICET BIO INC | 5 | 5 | 0.42% | 0.85% | 1.30% | Q1 2021 | Q1 2022 | 5 |
| VERV | VERVE THERAPEUTICS INC | 5 | 5 | 0.15% | 0.55% | 0.73% | Q3 2022 | Q3 2023 | 5 |
| NSTG | NANOSTRING TECHNOLOGIE... | 5 | 5 | 0.16% | 0.36% | 0.73% | Q3 2022 | Q3 2023 | 5 |
| S | SENTINELONE INC | 5 | 5 | 0.11% | 0.19% | 0.24% | Q2 2021 | Q2 2022 | 5 |
| SYROS PHARMACEUTICALS INC | 5 | 5 | 0.07% | 0.14% | 0.25% | Q3 2022 | Q3 2023 | 5 | |
| TANGO THERAPEUTICS INC | 5 | 5 | 0.06% | 0.10% | 0.16% | Q3 2021 | Q3 2022 | 5 | |
| SEMA4 HOLDINGS CORP | 5 | 5 | 0.02% | 0.09% | 0.28% | Q3 2021 | Q3 2022 | 5 | |
| DNAC | SOCIAL CAP SUVRETTA HL... | 5 | 5 | 0.04% | 0.05% | 0.06% | Q2 2021 | Q2 2022 | 5 |
| DNAA | SOCIAL CAP SUVRETTA HL... | 5 | 5 | 0.04% | 0.05% | 0.06% | Q2 2021 | Q2 2022 | 5 |
| MRK | MERCK & CO. INC | 1 | 1 | 2.12% | 3.95% | 5.23% | Q1 2020 | Q1 2023 | 4 |
| UNH | UNITEDHEALTH GROUP INC | 3 | 1 | 1.31% | 2.30% | 2.86% | Q4 2021 | Q3 2023 | 4 |
| THC | TENET HEALTHCARE CORP | 4 | 4 | 0.76% | 2.26% | 2.90% | Q4 2022 | Q3 2023 | 4 |
| CI | THE CIGNA GROUP | 2 | 1 | 0.90% | 2.19% | 3.87% | Q4 2019 | Q3 2023 | 4 |
| HOLX | HOLOGIC INC | 3 | 1 | 1.55% | 2.11% | 2.99% | Q2 2020 | Q4 2021 | 4 |
| UHS | UNIVERSAL HLTH SVCS INC | 4 | 4 | 0.92% | 2.08% | 2.83% | Q4 2022 | Q3 2023 | 4 |
| CAH | CARDINAL HEALTH INC | 3 | 1 | 1.01% | 2.05% | 3.35% | Q1 2020 | Q2 2021 | 4 |
| ESPR | ESPERION THERAPEUTICS ... | 3 | 1 | 0.23% | 1.97% | 4.90% | Q4 2019 | Q2 2021 | 4 |
| BIO | BIO RAD LABS INC | 4 | 4 | 0.84% | 1.90% | 3.52% | Q3 2022 | Q2 2023 | 4 |
| TRILLIUM THERAPEUTICS INC | 4 | 4 | 1.08% | 1.23% | 1.52% | Q3 2020 | Q2 2021 | 4 | |
| PLRX | PLIANT THERAPEUTICS INC | 4 | 4 | 0.58% | 1.18% | 2.35% | Q3 2022 | Q2 2023 | 4 |
| ITCI | INTRA-CELLULAR THERAPI... | 3 | 1 | 0.58% | 1.15% | 1.68% | Q2 2022 | Q3 2023 | 4 |
| VENTYX BIOSCIENCES INC | 4 | 4 | 0.50% | 1.08% | 2.13% | Q4 2022 | Q3 2023 | 4 | |
| BTAI | BIOXCEL THERAPEUTICS INC | 4 | 4 | 0.65% | 0.97% | 1.32% | Q1 2020 | Q4 2020 | 4 |
| BHC | BAUSCH HEALTH COS INC | 2 | 1 | 0.06% | 0.96% | 1.66% | Q4 2020 | Q2 2023 | 4 |
| ANIK | ANIKA THERAPEUTICS INC | 4 | 4 | 0.67% | 0.90% | 1.07% | Q1 2020 | Q4 2020 | 4 |
| BIOHAVEN LTD | 4 | 4 | 0.45% | 0.89% | 1.35% | Q4 2022 | Q3 2023 | 4 | |
| INSM | INSMED INC | 4 | 4 | 0.66% | 0.79% | 0.88% | Q2 2021 | Q1 2022 | 4 |
| MRSN | MERSANA THERAPEUTICS INC | 2 | 2 | 0.44% | 0.79% | 1.60% | Q2 2020 | Q2 2023 | 4 |
| KPTI | KARYOPHARM THERAPEUTIC... | 4 | 4 | 0.45% | 0.73% | 1.24% | Q4 2022 | Q3 2023 | 4 |
| FUSN | FUSION PHARMACEUTICALS... | 3 | 1 | 0.18% | 0.61% | 0.93% | Q2 2020 | Q3 2023 | 4 |
| ALDX | ALDEYRA THERAPEUTICS INC | 4 | 4 | 0.32% | 0.52% | 0.84% | Q3 2020 | Q2 2021 | 4 |
| PNT | POINT BIOPHARMA GLOBAL... | 4 | 4 | 0.38% | 0.48% | 0.58% | Q3 2022 | Q2 2023 | 4 |
| DCPH | DECIPHERA PHARMACEUTIC... | 3 | 1 | 0.36% | 0.45% | 0.60% | Q2 2020 | Q4 2022 | 4 |
| ZLAB | ZAI LAB LTD | 2 | 2 | 0.02% | 0.36% | 0.86% | Q2 2021 | Q4 2022 | 4 |
| TIL | INSTIL BIO INC | 4 | 4 | 0.15% | 0.20% | 0.28% | Q1 2021 | Q4 2021 | 4 |
| FIELD TRIP HEALTH LTD | 4 | 4 | 0.06% | 0.17% | 0.36% | Q3 2021 | Q2 2022 | 4 | |
| DYNS | DYNAMICS SPECIAL PURPO... | 4 | 4 | 0.10% | 0.11% | 0.13% | Q2 2021 | Q1 2022 | 4 |
| LSAQ | LIFESCI ACQUISITION II... | 4 | 4 | 0.09% | 0.11% | 0.14% | Q4 2020 | Q3 2021 | 4 |
| BCTG | BCTG ACQUISITION CORP | 4 | 4 | 0.09% | 0.11% | 0.14% | Q3 2020 | Q2 2021 | 4 |
| SCIENCE 37 HOLDINGS INC | 4 | 4 | 0.01% | 0.05% | 0.10% | Q4 2021 | Q3 2022 | 4 | |
| SGEN | SEATTLE GENETICS INC | 3 | 3 | 2.73% | 5.60% | 9.25% | Q1 2020 | Q3 2020 | 3 |
| MRVI | MARAVAI LIFESCIENCES H... | 3 | 3 | 2.72% | 3.07% | 3.34% | Q4 2020 | Q2 2021 | 3 |
| BDX | BECTON DICKINSON & CO | 3 | 3 | 2.37% | 3.01% | 3.67% | Q1 2023 | Q3 2023 | 3 |
| MNTA | MOMENTA PHARMACEUTICAL... | 3 | 3 | 2.45% | 2.62% | 2.93% | Q4 2019 | Q2 2020 | 3 |
| EXEL | EXELIXIS INC | 3 | 3 | 0.87% | 2.52% | 4.10% | Q1 2020 | Q3 2020 | 3 |
| BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.97% | 2.44% | 3.53% | Q1 2020 | Q1 2023 | 3 |
| IMMU | IMMUNOMEDICS INC | 3 | 3 | 0.92% | 2.38% | 4.34% | Q4 2019 | Q2 2020 | 3 |
| XBI | SPDR SER TR | 3 | 3 | 0.82% | 2.14% | 3.20% | Q1 2022 | Q3 2022 | 3 |
| DGX | QUEST DIAGNOSTICS INC | 2 | 1 | 0.87% | 2.02% | 3.06% | Q3 2020 | Q4 2022 | 3 |
| ASND | ASCENDIS PHARMA A S | 3 | 3 | 0.93% | 1.92% | 3.69% | Q4 2019 | Q2 2020 | 3 |
| ZTS | ZOETIS INC | 3 | 3 | 1.30% | 1.80% | 2.25% | Q1 2023 | Q3 2023 | 3 |
| PFE | PFIZER INC | 2 | 1 | 0.98% | 1.68% | 2.62% | Q3 2021 | Q2 2023 | 3 |
| CHRS | COHERUS BIOSCIENCES INC | 3 | 3 | 0.86% | 1.49% | 2.43% | Q4 2019 | Q2 2020 | 3 |
| PACB | PACIFIC BIOSCIENCES CA... | 3 | 3 | 0.35% | 1.28% | 2.02% | Q1 2023 | Q3 2023 | 3 |
| IMVT | IMMUNOVANT INC | 3 | 3 | 0.54% | 1.24% | 1.81% | Q1 2023 | Q3 2023 | 3 |
| CVAC | CUREVAC N V | 3 | 3 | 0.82% | 1.08% | 1.56% | Q1 2023 | Q3 2023 | 3 |
| BBIO | BRIDGEBIO PHARMA INC | 2 | 1 | 0.55% | 1.02% | 1.39% | Q1 2021 | Q1 2023 | 3 |
| ATHA | ATHIRA PHARMA INC | 3 | 3 | 0.85% | 0.96% | 1.16% | Q3 2020 | Q1 2021 | 3 |
| AMYLYX PHARMACEUTICALS... | 3 | 3 | 0.68% | 0.95% | 1.30% | Q1 2023 | Q3 2023 | 3 | |
| VRNA | VERONA PHARMA PLC | 3 | 3 | 0.54% | 0.61% | 0.70% | Q1 2023 | Q3 2023 | 3 |
| CRDF | CARDIFF ONCOLOGY INC | 3 | 3 | 0.25% | 0.61% | 0.94% | Q4 2020 | Q2 2021 | 3 |
| ORTX | ORCHARD THERAPEUTICS PLC | 3 | 3 | 0.20% | 0.50% | 0.87% | Q1 2021 | Q3 2021 | 3 |
| SANA | SANA BIOTECHNOLOGY INC | 3 | 3 | 0.39% | 0.49% | 0.68% | Q1 2021 | Q3 2021 | 3 |
| ARQT | ARCUTIS BIOTHERAPEUTIC... | 3 | 3 | 0.31% | 0.49% | 0.60% | Q3 2022 | Q1 2023 | 3 |
| XENE | XENON PHARMACEUTICALS INC | 2 | 1 | 0.31% | 0.47% | 0.65% | Q2 2022 | Q3 2023 | 3 |
| CYTK | CYTOKINETICS INC | 3 | 3 | 0.29% | 0.35% | 0.42% | Q3 2022 | Q1 2023 | 3 |
| VSPRU | VESPER HEALTHCARE ACQS... | 3 | 3 | 0.19% | 0.24% | 0.29% | Q3 2020 | Q1 2021 | 3 |
| COGT | COGENT BIOSCIENCES INC | 2 | 1 | 0.10% | 0.23% | 0.41% | Q4 2020 | Q3 2022 | 3 |
| KNTE | KINNATE BIOPHARMA INC | 3 | 3 | 0.16% | 0.23% | 0.30% | Q3 2022 | Q1 2023 | 3 |
| HOWL | WEREWOLF THERAPEUTICS INC | 3 | 3 | 0.12% | 0.22% | 0.31% | Q2 2021 | Q4 2021 | 3 |
| SGMO | SANGAMO THERAPEUTICS INC | 3 | 3 | 0.14% | 0.19% | 0.24% | Q3 2022 | Q1 2023 | 3 |
| GLUE | MONTE ROSA THERAPEUTIC... | 3 | 3 | 0.13% | 0.15% | 0.18% | Q2 2021 | Q4 2021 | 3 |
| ERASCA INC | 3 | 3 | 0.13% | 0.15% | 0.18% | Q1 2022 | Q3 2022 | 3 | |
| TALS | TALARIS THERAPEUTICS INC | 3 | 3 | 0.14% | 0.15% | 0.17% | Q2 2021 | Q4 2021 | 3 |
| HCAQ | HEALTHCOR CATALIO ACQU... | 3 | 3 | 0.11% | 0.13% | 0.14% | Q1 2021 | Q3 2021 | 3 |
| BCAB | BIOATLA INC | 2 | 1 | 0.05% | 0.11% | 0.22% | Q4 2020 | Q1 2023 | 3 |
| ANNX | ANNEXON INC | 3 | 3 | 0.05% | 0.05% | 0.06% | Q3 2020 | Q1 2021 | 3 |
| AMWL | AMERICAN WELL CORP | 3 | 3 | 0.03% | 0.05% | 0.07% | Q3 2020 | Q1 2021 | 3 |
| REUNION NEUROSCIENCE INC | 3 | 3 | 0.00% | 0.01% | 0.02% | Q3 2022 | Q1 2023 | 3 | |
| XBI | SPDR SER TR | 1 | 1 | 7.30% | 7.86% | 8.41% | Q3 2021 | Q4 2022 | 2 |
| SPDR SER TR | 1 | 1 | 6.18% | 6.36% | 6.53% | Q1 2022 | Q3 2022 | 2 | |
| HCA | HCA HEALTHCARE INC | 1 | 1 | 1.14% | 3.49% | 5.84% | Q4 2019 | Q3 2023 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS... | 1 | 1 | 1.44% | 3.29% | 5.14% | Q4 2019 | Q1 2021 | 2 |
| ALXN | ALEXION PHARMACEUTICAL... | 2 | 2 | 1.98% | 2.82% | 3.65% | Q1 2020 | Q2 2020 | 2 |
| EW | EDWARDS LIFESCIENCES CORP | 1 | 1 | 1.08% | 2.52% | 3.97% | Q4 2019 | Q1 2022 | 2 |
| JNJ | JOHNSON & JOHNSON | 2 | 2 | 1.31% | 2.49% | 3.67% | Q1 2022 | Q2 2022 | 2 |
| ISRG | INTUITIVE SURGICAL INC | 1 | 1 | 2.04% | 2.44% | 2.85% | Q1 2021 | Q1 2022 | 2 |
| BIOGEN INC | 2 | 2 | 1.97% | 2.39% | 2.82% | Q3 2020 | Q4 2020 | 2 | |
| AXNX | AXONICS MODULATION TEC... | 1 | 1 | 0.67% | 2.15% | 3.63% | Q4 2019 | Q2 2023 | 2 |
| QURE | UNIQURE NV | 2 | 2 | 1.55% | 2.02% | 2.48% | Q4 2019 | Q1 2020 | 2 |
| BMYRT | BRISTOL-MYERS SQUIBB CO | 2 | 2 | 1.33% | 1.85% | 2.37% | Q2 2020 | Q3 2020 | 2 |
| CHNG | CHANGE HEALTHCARE INC | 2 | 2 | 1.70% | 1.78% | 1.87% | Q3 2020 | Q4 2020 | 2 |
| MDGL | MADRIGAL PHARMACEUTICA... | 1 | 1 | 0.86% | 1.78% | 2.70% | Q4 2019 | Q4 2022 | 2 |
| ALEC | ALECTOR INC | 2 | 2 | 1.08% | 1.73% | 2.38% | Q1 2020 | Q2 2020 | 2 |
| ABC | AMERISOURCEBERGEN CORP | 2 | 2 | 0.67% | 1.34% | 2.02% | Q1 2023 | Q2 2023 | 2 |
| STEVANATO GROUP S P A | 2 | 2 | 1.21% | 1.32% | 1.42% | Q3 2021 | Q4 2021 | 2 | |
| IMGN | IMMUNOGEN INC | 2 | 2 | 1.23% | 1.27% | 1.32% | Q2 2023 | Q3 2023 | 2 |
| MOONLAKE IMMUNOTHERAPE... | 2 | 2 | 0.71% | 1.25% | 1.78% | Q2 2023 | Q3 2023 | 2 | |
| PRVA | PRIVIA HEALTH GROUP INC | 2 | 2 | 0.98% | 1.21% | 1.43% | Q2 2023 | Q3 2023 | 2 |
| LNTH | LANTHEUS HLDGS INC | 2 | 2 | 0.72% | 1.14% | 1.56% | Q2 2023 | Q3 2023 | 2 |
| CNC | CENTENE CORP DEL | 1 | 1 | 0.68% | 1.08% | 1.48% | Q2 2021 | Q3 2022 | 2 |
| ORGO | ORGANOGENESIS HLDGS INC | 2 | 2 | 0.74% | 1.04% | 1.35% | Q4 2020 | Q1 2021 | 2 |
| EDIT | EDITAS MEDICINE INC | 1 | 1 | 0.86% | 1.00% | 1.14% | Q2 2020 | Q2 2023 | 2 |
| ICLR | ICON PLC | 2 | 2 | 0.90% | 0.96% | 1.01% | Q4 2022 | Q1 2023 | 2 |
| CMPS | COMPASS PATHWAYS PLC | 2 | 2 | 0.77% | 0.90% | 1.03% | Q2 2021 | Q3 2021 | 2 |
| OCDX | ORTHO CLINICAL DIAGNOS... | 2 | 2 | 0.81% | 0.90% | 0.98% | Q3 2021 | Q4 2021 | 2 |
| SYNH | SYNEOS HEALTH INC | 1 | 1 | 0.42% | 0.90% | 1.37% | Q2 2020 | Q2 2021 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTI... | 2 | 2 | 0.77% | 0.85% | 0.92% | Q2 2020 | Q3 2020 | 2 |
| SGTX | SIGILON THERAPEUTICS INC | 2 | 2 | 0.52% | 0.80% | 1.07% | Q4 2020 | Q1 2021 | 2 |
| KYMR | KYMERA THERAPEUTICS INC | 2 | 2 | 0.67% | 0.79% | 0.90% | Q3 2021 | Q4 2021 | 2 |
| RCUS | ARCUS BIOSCIENCES INC | 1 | 1 | 0.60% | 0.77% | 0.93% | Q2 2020 | Q1 2022 | 2 |
| VSTM | VERASTEM INC | 2 | 2 | 0.49% | 0.75% | 1.02% | Q1 2020 | Q2 2020 | 2 |
| ZYME | ZYMEWORKS INC | 2 | 2 | 0.53% | 0.71% | 0.89% | Q3 2020 | Q4 2020 | 2 |
| BNTX | BIONTECH SE | 1 | 1 | 0.66% | 0.68% | 0.70% | Q3 2020 | Q4 2022 | 2 |
| ROIVANT SCIENCES LTD | 2 | 2 | 0.59% | 0.65% | 0.71% | Q2 2023 | Q3 2023 | 2 | |
| ETNB | 89BIO INC | 2 | 2 | 0.35% | 0.64% | 0.93% | Q1 2023 | Q2 2023 | 2 |
| CRIS | CURIS INC | 2 | 2 | 0.62% | 0.63% | 0.64% | Q4 2020 | Q1 2021 | 2 |
| KNSA | KINIKSA PHARMACEUTICAL... | 2 | 2 | 0.55% | 0.62% | 0.68% | Q4 2020 | Q1 2021 | 2 |
| LGND | LIGAND PHARMACEUTICALS... | 1 | 1 | 0.20% | 0.61% | 1.02% | Q1 2020 | Q4 2020 | 2 |
| LFST | LIFESTANCE HEALTH GROU... | 2 | 2 | 0.32% | 0.57% | 0.83% | Q2 2021 | Q3 2021 | 2 |
| CERE | CEREVEL THERAPEUTICS H... | 2 | 2 | 0.56% | 0.56% | 0.56% | Q2 2023 | Q3 2023 | 2 |
| MINERALYS THERAPEUTICS... | 2 | 2 | 0.46% | 0.56% | 0.66% | Q1 2023 | Q2 2023 | 2 | |
| STRUCTURE THERAPEUTICS... | 2 | 2 | 0.06% | 0.54% | 1.02% | Q2 2023 | Q3 2023 | 2 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2 | 2 | 0.40% | 0.47% | 0.54% | Q4 2021 | Q1 2022 | 2 |
| SDGR | SCHRODINGER INC | 2 | 2 | 0.45% | 0.47% | 0.48% | Q2 2023 | Q3 2023 | 2 |
| PATH | UIPATH INC | 2 | 2 | 0.37% | 0.46% | 0.55% | Q2 2021 | Q3 2021 | 2 |
| IGMS | IGM BIOSCIENCES INC | 2 | 2 | 0.23% | 0.42% | 0.62% | Q4 2020 | Q1 2021 | 2 |
| NKTX | NKARTA INC | 2 | 2 | 0.38% | 0.39% | 0.40% | Q2 2022 | Q3 2022 | 2 |
| TSHA | TAYSHA GENE THERAPIES INC | 2 | 2 | 0.34% | 0.37% | 0.41% | Q3 2020 | Q4 2020 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 2 | 2 | 0.32% | 0.36% | 0.41% | Q4 2022 | Q1 2023 | 2 |
| AVDL | AVADEL PHARMACEUTICALS... | 2 | 2 | 0.24% | 0.33% | 0.42% | Q1 2020 | Q2 2020 | 2 |
| GHRS | GH RESEARCH PLC | 2 | 2 | 0.27% | 0.30% | 0.33% | Q2 2021 | Q3 2021 | 2 |
| RLMD | RELMADA THERAPEUTICS INC | 1 | 1 | 0.25% | 0.30% | 0.35% | Q4 2019 | Q4 2021 | 2 |
| OSH | OAK STR HEALTH INC | 2 | 2 | 0.25% | 0.27% | 0.30% | Q3 2020 | Q4 2020 | 2 |
| SNSS | SUNESIS PHARMACEUTICAL... | 2 | 2 | 0.25% | 0.27% | 0.30% | Q4 2019 | Q1 2020 | 2 |
| PHVS | PHARVARIS N V | 2 | 2 | 0.20% | 0.26% | 0.31% | Q1 2021 | Q2 2021 | 2 |
| ITOS | ITEOS THERAPEUTICS INC | 2 | 2 | 0.10% | 0.24% | 0.38% | Q3 2020 | Q4 2020 | 2 |
| DNLI | DENALI THERAPEUTICS INC | 1 | 1 | 0.18% | 0.24% | 0.29% | Q2 2021 | Q2 2023 | 2 |
| ZETA | ZETA GLOBAL HOLDINGS CORP | 2 | 2 | 0.17% | 0.23% | 0.30% | Q2 2021 | Q3 2021 | 2 |
| CMLF | CM LIFE SCIENCES INC | 2 | 2 | 0.20% | 0.21% | 0.23% | Q1 2021 | Q2 2021 | 2 |
| OM | OUTSET MED INC | 2 | 2 | 0.18% | 0.21% | 0.23% | Q3 2020 | Q4 2020 | 2 |
| NAUT | NAUTILUS BIOTECHNOLOGY... | 2 | 2 | 0.08% | 0.19% | 0.31% | Q2 2021 | Q3 2021 | 2 |
| ARYA | ARYA SCIENCES ACQUISIT... | 2 | 2 | 0.18% | 0.18% | 0.19% | Q4 2020 | Q1 2021 | 2 |
| MRUS | MERUS N V | 1 | 1 | 0.07% | 0.18% | 0.28% | Q1 2021 | Q4 2021 | 2 |
| CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.04% | 0.16% | 0.27% | Q3 2020 | Q2 2021 | 2 |
| PANAU | PANACEA ACQUISITION CORP | 2 | 2 | 0.12% | 0.15% | 0.17% | Q3 2020 | Q4 2020 | 2 |
| ATAI | ATAI LIFE SCIENCES NV | 2 | 2 | 0.07% | 0.12% | 0.18% | Q2 2021 | Q3 2021 | 2 |
| CMIIU | CM LIFE SCIENCES II INC | 2 | 2 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q2 2021 | 2 |
| KROS | KEROS THERAPEUTICS INC | 1 | 1 | 0.09% | 0.11% | 0.13% | Q4 2020 | Q3 2021 | 2 |
| SOMALOGIC INC | 2 | 2 | 0.08% | 0.09% | 0.09% | Q3 2021 | Q4 2021 | 2 | |
| ZIOP | ZIOPHARM ONCOLOGY INC | 2 | 2 | 0.01% | 0.07% | 0.12% | Q3 2021 | Q4 2021 | 2 |
| NRIX | NURIX THERAPEUTICS INC | 2 | 2 | 0.05% | 0.07% | 0.08% | Q3 2020 | Q4 2020 | 2 |
| ACCD | ACCOLADE INC | 2 | 2 | 0.06% | 0.06% | 0.07% | Q3 2020 | Q4 2020 | 2 |
| OTIC | OTONOMY INC | 2 | 2 | 0.05% | 0.06% | 0.07% | Q1 2022 | Q2 2022 | 2 |
| RLAY | RELAY THERAPEUTICS INC | 2 | 2 | 0.04% | 0.05% | 0.06% | Q3 2020 | Q4 2020 | 2 |
| INZY | INOZYME PHARMA INC | 2 | 2 | 0.01% | 0.04% | 0.08% | Q3 2020 | Q4 2020 | 2 |
| SOMALOGIC INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2021 | Q4 2021 | 2 | |
| - | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2019 | Q1 2020 | 2 | |
| PFIZER INC | 1 | 1 | 11.06% | 11.06% | 11.06% | Q3 2020 | Q3 2020 | 1 | |
| XLRN | ACCELERON PHARMA INC | 1 | 1 | 4.68% | 4.68% | 4.68% | Q3 2021 | Q3 2021 | 1 |
| NXTC | NEXTCURE INC | 1 | 1 | 3.30% | 3.30% | 3.30% | Q4 2019 | Q4 2019 | 1 |
| GE HEALTHCARE TECHNOLO... | 1 | 1 | 2.97% | 2.97% | 2.97% | Q2 2023 | Q2 2023 | 1 | |
| ABEO | ABEONA THERAPEUTICS INC | 1 | 1 | 2.73% | 2.73% | 2.73% | Q4 2019 | Q4 2019 | 1 |
| TMO | THERMO FISHER SCIENTIF... | 1 | 1 | 2.42% | 2.42% | 2.42% | Q3 2020 | Q3 2020 | 1 |
| CVS | CVS HEALTH CORP | 1 | 1 | 2.27% | 2.27% | 2.27% | Q1 2020 | Q1 2020 | 1 |
| PRNB | PRINCIPIA BIOPHARMA INC | 1 | 1 | 2.10% | 2.10% | 2.10% | Q2 2020 | Q2 2020 | 1 |
| GILD | GILEAD SCIENCES INC | 1 | 1 | 2.07% | 2.07% | 2.07% | Q1 2020 | Q1 2020 | 1 |
| SGEN | SEATTLE GENETICS INC | 1 | 1 | 1.88% | 1.88% | 1.88% | Q1 2020 | Q1 2020 | 1 |
| QDEL | QUIDEL CORP | 1 | 1 | 1.80% | 1.80% | 1.80% | Q3 2020 | Q3 2020 | 1 |
| DHR | DANAHER CORPORATION | 1 | 1 | 1.76% | 1.76% | 1.76% | Q3 2023 | Q3 2023 | 1 |
| NEO | NEOGENOMICS INC | 1 | 1 | 1.67% | 1.67% | 1.67% | Q2 2021 | Q2 2021 | 1 |
| NLTX | NEOLEUKIN THERAPEUTICS... | 1 | 1 | 1.63% | 1.63% | 1.63% | Q4 2019 | Q4 2019 | 1 |
| MRNA | MODERNA INC | 1 | 1 | 1.51% | 1.51% | 1.51% | Q1 2020 | Q1 2020 | 1 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1 | 1 | 1.45% | 1.45% | 1.45% | Q3 2023 | Q3 2023 | 1 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 1 | 1 | 1.45% | 1.45% | 1.45% | Q4 2020 | Q4 2020 | 1 |
| CRSP | CRISPR THERAPEUTICS AG | 1 | 1 | 1.29% | 1.29% | 1.29% | Q2 2020 | Q2 2020 | 1 |
| ABT | ABBOTT LABS | 1 | 1 | 1.19% | 1.19% | 1.19% | Q1 2023 | Q1 2023 | 1 |
| ABMD | ABIOMED INC | 1 | 1 | 1.17% | 1.17% | 1.17% | Q1 2021 | Q1 2021 | 1 |
| INO | INOVIO PHARMACEUTICALS... | 1 | 1 | 1.03% | 1.03% | 1.03% | Q1 2021 | Q1 2021 | 1 |
| IRWD | IRONWOOD PHARMACEUTICA... | 1 | 1 | 1.02% | 1.02% | 1.02% | Q1 2020 | Q1 2020 | 1 |
| NEUMORA THERAPEUTICS INC. | 1 | 1 | 1.02% | 1.02% | 1.02% | Q3 2023 | Q3 2023 | 1 | |
| CRL | CHARLES RIV LABS INTL INC | 1 | 1 | 0.99% | 0.99% | 0.99% | Q1 2020 | Q1 2020 | 1 |
| BIOHAVEN PHARMACTL HLD... | 1 | 1 | 0.99% | 0.99% | 0.99% | Q1 2021 | Q1 2021 | 1 | |
| PRVL | PREVAIL THERAPEUTICS INC | 1 | 1 | 0.98% | 0.98% | 0.98% | Q2 2020 | Q2 2020 | 1 |
| AGN | ALLERGAN PLC | 1 | 1 | 0.98% | 0.98% | 0.98% | Q1 2020 | Q1 2020 | 1 |
| AERI | AERIE PHARMACEUTICALS INC | 1 | 1 | 0.95% | 0.95% | 0.95% | Q1 2020 | Q1 2020 | 1 |
| AMRN | AMARIN CORP PLC | 1 | 1 | 0.90% | 0.90% | 0.90% | Q1 2020 | Q1 2020 | 1 |
| AMRN | AMARIN CORP PLC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q3 2020 | Q3 2020 | 1 |
| AKBA | AKEBIA THERAPEUTICS INC | 1 | 1 | 0.85% | 0.85% | 0.85% | Q3 2020 | Q3 2020 | 1 |
| NERV | MINERVA NEUROSCIENCES INC | 1 | 1 | 0.82% | 0.82% | 0.82% | Q1 2020 | Q1 2020 | 1 |
| CGEM | CULLINAN ONCOLOGY INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q1 2021 | Q1 2021 | 1 |
| AIMT | AIMMUNE THERAPEUTICS INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q1 2020 | Q1 2020 | 1 |
| ATRC | ATRICURE INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q4 2020 | Q4 2020 | 1 |
| SYK | STRYKER CORPORATION | 1 | 1 | 0.76% | 0.76% | 0.76% | Q3 2022 | Q3 2022 | 1 |
| CRNX | CRINETICS PHARMACEUTIC... | 1 | 1 | 0.73% | 0.73% | 0.73% | Q3 2023 | Q3 2023 | 1 |
| AMN | AMN HEALTHCARE SVCS INC | 1 | 1 | 0.73% | 0.73% | 0.73% | Q4 2021 | Q4 2021 | 1 |
| DIANTHUS THERAPEUTICS INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q3 2023 | Q3 2023 | 1 | |
| SURF | SURFACE ONCOLOGY INC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q2 2020 | Q2 2020 | 1 |
| RPRX | ROYALTY PHARMA PLC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q2 2020 | Q2 2020 | 1 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q1 2021 | Q1 2021 | 1 |
| CMRX | CHIMERIX INC | 1 | 1 | 0.59% | 0.59% | 0.59% | Q1 2021 | Q1 2021 | 1 |
| ACELYRIN INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q2 2023 | Q2 2023 | 1 | |
| ARKG | ARK ETF TR | 1 | 1 | 0.54% | 0.54% | 0.54% | Q2 2022 | Q2 2022 | 1 |
| GBT | GLOBAL BLOOD THERAPEUT... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q4 2021 | Q4 2021 | 1 |
| BVS | BIOVENTUS INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q1 2021 | Q1 2021 | 1 |
| RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q4 2020 | Q4 2020 | 1 |
| RXDX | PROMETHEUS BIOSCIENCES... | 1 | 1 | 0.49% | 0.49% | 0.49% | Q4 2022 | Q4 2022 | 1 |
| PEN | PENUMBRA INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2022 | Q1 2022 | 1 |
| NGM | NGM BIOPHARMACEUTICALS... | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2022 | Q3 2022 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2023 | Q3 2023 | 1 |
| 2SEVENTY BIO INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q2 2023 | Q2 2023 | 1 | |
| ONEM | 1LIFE HEALTHCARE INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q2 2020 | Q2 2020 | 1 |
| AKUS | AKOUOS INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q2 2020 | Q2 2020 | 1 |
| RAYZEBIO INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2023 | Q3 2023 | 1 | |
| CERT | CERTARA INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2020 | Q4 2020 | 1 |
| STRO | SUTRO BIOPHARMA INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2020 | Q4 2020 | 1 |
| CDXS | CODEXIS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2020 | Q4 2020 | 1 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2020 | Q4 2020 | 1 |
| NERV | MINERVA NEUROSCIENCES INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q1 2020 | Q1 2020 | 1 |
| KURA | KURA ONCOLOGY INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q4 2020 | Q4 2020 | 1 |
| BGNE | BEIGENE LTD | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2022 | Q3 2022 | 1 |
| NARI | INARI MED INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q2 2023 | Q2 2023 | 1 |
| GOSS | GOSSAMER BIO INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2022 | Q3 2022 | 1 |
| RTRX | RETROPHIN INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2020 | Q2 2020 | 1 |
| CSTL | CASTLE BIOSCIENCES INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q4 2020 | Q4 2020 | 1 |
| ADMS | ADAMAS PHARMACEUTICALS... | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2021 | Q1 2021 | 1 |
| AFMD | AFFIMED N V | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2021 | Q1 2021 | 1 |
| GLPG | GALAPAGOS NV | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2022 | Q1 2022 | 1 |
| IMTX | IMMATICS N.V | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2021 | Q1 2021 | 1 |
| ARAV | ARAVIVE INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2019 | Q4 2019 | 1 |
| TMDX | TRANSMEDICS GROUP INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2022 | Q3 2022 | 1 |
| ARYBU | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2020 | Q3 2020 | 1 |
| PMVP | PMV PHARMACEUTICALS INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2020 | Q3 2020 | 1 |
| TERN | TERNS PHARMACEUTICALS INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2021 | Q1 2021 | 1 |
| MNDY | MONDAY COM LTD | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2021 | Q2 2021 | 1 |
| EVLO | EVELO BIOSCIENCES INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2021 | Q1 2021 | 1 |
| DOCS | DOXIMITY INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2021 | Q2 2021 | 1 |
| STOK | STOKE THERAPEUTICS INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q3 2022 | Q3 2022 | 1 |
| ENGAGESMART INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2021 | Q3 2021 | 1 | |
| ZGNX | ZOGENIX INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2020 | Q2 2020 | 1 |
| OCUL | OCULAR THERAPEUTIX INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2020 | Q4 2020 | 1 |
| FPRX | FIVE PRIME THERAPEUTIC... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2020 | Q4 2020 | 1 |
| GERN | GERON CORP | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2023 | Q1 2023 | 1 |
| ALBO | ALBIREO PHARMA INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2020 | Q4 2020 | 1 |
| EQRX INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2021 | Q4 2021 | 1 | |
| DEFINITIVE HEALTHCARE ... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2021 | Q4 2021 | 1 | |
| MSACU | MEDICUS SCIENCES ACQUI... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2021 | Q1 2021 | 1 |
| PROG | PROGENITY INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2020 | Q2 2020 | 1 |
| FIGS | FIGS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2021 | Q2 2021 | 1 |
| CELC | CELCUITY INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2021 | Q2 2021 | 1 |
| CFLT | CONFLUENT INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2021 | Q2 2021 | 1 |
| WKME | WALKME LTD | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2021 | Q2 2021 | 1 |
| PRAX | PRAXIS PRECISION MEDIC... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2023 | Q1 2023 | 1 |
| ENTRADA THERAPEUTICS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2021 | Q4 2021 | 1 | |
| BLI | BERKELEY LTS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q3 2020 | Q3 2020 | 1 |
| SIGHT SCIENCES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2021 | Q3 2021 | 1 | |
| SLP | SIMULATIONS PLUS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2023 | Q2 2023 | 1 |
| EYPT | EYEPOINT PHARMACEUTICA... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2021 | Q1 2021 | 1 |
| TKNO | ALPHA TEKNOVA INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2021 | Q2 2021 | 1 |
| FLYW | FLYWIRE CORPORATION | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2021 | Q2 2021 | 1 |
| OMIC | SINGULAR GENOMICS SYST... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2021 | Q2 2021 | 1 |
| NPCE | NEUROPACE INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2021 | Q2 2021 | 1 |
| EXSCIENTIA PLC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2023 | Q2 2023 | 1 | |
| FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2022 | Q4 2022 | 1 |
| ARTERIS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 | |
Download | |||||||||
The securities at the top of the list , including NEUROCRINE BIOSCIENCES INC, ARVINAS INC, and ZENTALIS PHARMACEUTICALS INC, are the highest-conviction holdings of Avidity Partners Management LP.
The conviction is calculated by counting the number of quarters a security has been reported by Avidity Partners Management LP. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Avidity Partners Management LP owns currently or has owned in the past.